Abstract
Highlights
•MyD88 absence upregulates Dectin-1 in adipose tissue (AT) and AT macrophages (ATMs)
•Dectin-1 inhibition decreases CD11c+ ATMs and protects mice from insulin resistance (IR)
•Dectin-1 activation increases CD11c+ ATMs and worsens IR
•Obese humans have increased Dectin-1 expression in AT
Summary
The underlying mechanism by which MyD88 regulates the development of obesity, metainflammation, and insulin resistance (IR) remains unknown. Global deletion of MyD88 in high-fat diet (HFD)-fed mice resulted in increased weight gain, impaired glucose homeostasis, elevated Dectin-1 expression in adipose tissue (AT), and proinflammatory CD11c+ AT macrophages (ATMs). Dectin-1 KO mice were protected from diet-induced obesity (DIO) and IR and had reduced CD11c+ AT macrophages. Dectin-1 antagonist improved glucose homeostasis and decreased CD11c+ AT macrophages in chow- and HFD-fed MyD88 KO mice. Dectin-1 agonist worsened glucose homeostasis in MyD88 KO mice. Dectin-1 expression is increased in AT from obese individuals. Together, our data indicate that Dectin-1 regulates AT inflammation by promoting CD11c+ AT macrophages in the absence of MyD88 and identify a role for Dectin-1 in chronic inflammatory states, such as obesity. This suggests that Dectin-1 may have therapeutic implications as a biomarker for metabolic dysregulation in humans.
•MyD88 absence upregulates Dectin-1 in adipose tissue (AT) and AT macrophages (ATMs)
•Dectin-1 inhibition decreases CD11c+ ATMs and protects mice from insulin resistance (IR)
•Dectin-1 activation increases CD11c+ ATMs and worsens IR
•Obese humans have increased Dectin-1 expression in AT
Summary
The underlying mechanism by which MyD88 regulates the development of obesity, metainflammation, and insulin resistance (IR) remains unknown. Global deletion of MyD88 in high-fat diet (HFD)-fed mice resulted in increased weight gain, impaired glucose homeostasis, elevated Dectin-1 expression in adipose tissue (AT), and proinflammatory CD11c+ AT macrophages (ATMs). Dectin-1 KO mice were protected from diet-induced obesity (DIO) and IR and had reduced CD11c+ AT macrophages. Dectin-1 antagonist improved glucose homeostasis and decreased CD11c+ AT macrophages in chow- and HFD-fed MyD88 KO mice. Dectin-1 agonist worsened glucose homeostasis in MyD88 KO mice. Dectin-1 expression is increased in AT from obese individuals. Together, our data indicate that Dectin-1 regulates AT inflammation by promoting CD11c+ AT macrophages in the absence of MyD88 and identify a role for Dectin-1 in chronic inflammatory states, such as obesity. This suggests that Dectin-1 may have therapeutic implications as a biomarker for metabolic dysregulation in humans.
Original language | English |
---|---|
Pages (from-to) | 2272-2288 |
Number of pages | 7 |
Journal | Cell Reports |
Volume | 19 |
Issue number | 11 |
DOIs | |
Publication status | Published - 13 Jun 2017 |
Bibliographical note
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant numbers 11/15682-4, 12/02270-2, 15/18121-4), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Regenera INCT Process Grant 465656/2014-5). JL is funded by the NIH/NIDDK R01DK106210. GDB is funded by the Wellcome Trust and the MRC Centre for Medical Mycology.Open access journal
Keywords
- MyD88
- Dectin-1
- insulin resistance
- inflammation
- macrophage
- adipose tissue